It is a dual GIP and GLP-1 receptor agonist, meaning it targets two hormonesglucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)to regulate blood sugar levels, reduce appetite, and improve fat metabolism
Table 1 Changes in gut microbiota after administration of metformin therapy
Once significant weight loss is achieved, some individuals may continue the medication at a lower maintenance dose, while others may transition to other weight management strategies
Sip it in the morning or before your workout
Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period
Black garlic: A critical review of its production, bioactivity, and application